Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes

[1]  J. Fraumeni,et al.  Cancer epidemiology and prevention. , 2006 .

[2]  M. J. Lee.  Epidemiology and Risk Factors in Pancreatic Cancer. , 2004 .

[3]  Maurice Whelan,et al.  Feasibility, sensitivity, and reliability of laser-induced fluorescence imaging of green fluorescent protein-expressing tumors in vivo. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  J. Lehn,et al.  Aminoglycoside‐derived cationic lipids as efficient vectors for gene transfection in vitro and in vivo , 2002, The journal of gene medicine.

[5]  J. Lehn,et al.  Progress in gene delivery by cationic lipids: guanidinium-cholesterol-based systems as an example. , 2002, Current drug targets.

[6]  G. Zuber,et al.  Towards synthetic viruses. , 2001, Advanced drug delivery reviews.

[7]  D. Scherman,et al.  Sterically stabilized BGTC‐based lipoplexes: structural features and gene transfection into the mouse airways in vivo , 2001, The journal of gene medicine.

[8]  A. Stopeck,et al.  Phase II Study of Direct Intralesional Gene Transfer of Allovectin-7, an HLA-B7/β2-Microglobulin DNA-Liposome Complex, in Patients with Metastatic Melanoma , 2001 .

[9]  S. Carotta,et al.  Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo , 2001, The journal of gene medicine.

[10]  S. Simões,et al.  Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. , 2001, Advanced drug delivery reviews.

[11]  Teruhiko Yoshida,et al.  Polyethylenimine-mediated gene transfer into pancreatic tumor dissemination in the murine peritoneal cavity , 2001, Gene Therapy.

[12]  O. Danos,et al.  Polyethylenimine‐mediated gene delivery: a mechanistic study , 2001, The journal of gene medicine.

[13]  J. Minna,et al.  Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  J. Lehn,et al.  Efficient gene transfection by bisguanylated diacetylene lipid formulations. , 2001, Biochemical and biophysical research communications.

[15]  L. Taichman,et al.  Suicide gene therapy for premalignant disease: a new strategy for the treatment of intraepithelial neoplasia , 2001, Gene Therapy.

[16]  R. Kim,et al.  Enhancement of antitumor effect by intratumoral administration of bax gene in combination with anticancer drugs in gastric cancer. , 2001, International journal of oncology.

[17]  Eithne Costello,et al.  Gene therapy for pancreatic cancer--current and prospective strategies. , 2000, Surgical oncology.

[18]  D. Klatzmann,et al.  Efficient suicide gene therapy of transduced and distant untransduced ovary tumors is correlated with significant increase of intratumoral T and NK cells. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[19]  M. Zöller,et al.  Induction of protective immunity against syngeneic rat cancer cells by expression of the cytosine deaminase suicide gene , 2000, Cancer Gene Therapy.

[20]  X. Breakefield,et al.  Prodrug activation enzymes in cancer gene therapy , 2000, The journal of gene medicine.

[21]  C. Springer,et al.  Prodrug-activating systems in suicide gene therapy. , 2000, The Journal of clinical investigation.

[22]  S. Sakiyama,et al.  Expression of Escherichia coli uracil phosphoribosyltransferase gene in murine colon carcinoma cells augments the antitumoral effect of 5-fluorouracil and induces protective immunity , 2000, Cancer Gene Therapy.

[23]  R. Figlin,et al.  Intratumoral interleukin 2 for renal-cell carcinoma by direct gene transfer of a plasmid DNA/DMRIE/DOPE lipid complex , 2000, World Journal of Urology.

[24]  M. Cotten,et al.  Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus , 2000, Gene Therapy.

[25]  S. Kong,et al.  Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregates. , 1999, The Journal of pharmacology and experimental therapeutics.

[26]  D. Scherman,et al.  Structural characteristics of supramolecular assemblies formed by guanidinium-cholesterol reagents for gene transfection. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Férec,et al.  New biocompatible cationic amphiphiles derivative from glycine betaine: a novel family of efficient nonviral gene transfer agents. , 1998, Biochemical and biophysical research communications.

[28]  Andrew D. Miller.  Cationic Liposomes for Gene Therapy , 1998 .

[29]  J. Williams,et al.  Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo. , 1998, Human gene therapy.

[30]  J. H. Kim,et al.  A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy. , 1998, Human gene therapy.

[31]  S. Cascinu,et al.  Chemotherapy for Advanced Pancreatic Cancer: The History is Changing , 1998, Tumori.

[32]  Y. Shiratori,et al.  Adenovirus-mediated transduction of Escherichia coli uracil phosphoribosyltransferase gene sensitizes cancer cells to low concentrations of 5-fluorouracil. , 1998, Cancer research.

[33]  X. Breakefield,et al.  Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies. , 1998, Journal of the National Cancer Institute.

[34]  N. Oudrhiri,et al.  Gene delivery systems: Bridging the gap between recombinant viruses and artificial vectors. , 1998, Advanced drug delivery reviews.

[35]  J. Zabner,et al.  A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epithelia , 1997, Gene Therapy.

[36]  T. Sugimura,et al.  Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene. , 1997, Human gene therapy.

[37]  Colin D. Johnson.  Prognosis in pancreatic cancer , 1997, The Lancet.

[38]  J. Neoptolemos,et al.  Adjuvant chemotherapy in pancreatic cancer , 1997, International journal of pancreatology : official journal of the International Association of Pancreatology.

[39]  C. Springer,et al.  Gene-directed enzyme prodrug therapy with a mustard prodrug/carboxypeptidase G2 combination. , 1996, Cancer research.

[40]  J. Lehn,et al.  Guanidinium-cholesterol cationic lipids: efficient vectors for the transfection of eukaryotic cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Piccoli,et al.  Survival after resection for ductal adenocarcinoma of the pancreas , 1996, The British journal of surgery.

[42]  Ahlgren Jd.  Epidemiology and risk factors in pancreatic cancer , 1996 .

[43]  C. Springer,et al.  Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954. , 1995, European journal of cancer.

[44]  Xiang Gao,et al.  Cationic liposome-mediated gene transfer. , 1995, Gene therapy.

[45]  F. Ledley.  Nonviral gene therapy: the promise of genes as pharmaceutical products. , 1995, Human gene therapy.

[46]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[47]  F. Moolten.  Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. , 1986, Cancer research.

[48]  F. Gansauge,et al.  Pancreatic cancer: who benefits from curative resection? , 2002, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[49]  S. Gerson,et al.  Cancer gene therapy: scientific basis. , 2002, Annual review of medicine.

[50]  J. Thompson,et al.  Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[51]  D. Curiel,et al.  Progress in cancer gene therapy , 2000, Cancer Gene Therapy.

[52]  Leaf Huang,et al.  Nonviral gene therapy: promises and challenges , 2000, Gene Therapy.

[53]  S. Kuriyama,et al.  Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma. , 1999, Scandinavian journal of gastroenterology.

[54]  J. Lehn,et al.  Guanidinium-cholesterol cationic lipids : novel reagents for gene transfection and perspectives for gene therapy , 1998 .

[55]  S. Kim,et al.  Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. , 1997, Human gene therapy.

[56]  I. Stratford,et al.  Targeting gene therapy to cancer: a review. , 1997, Oncology research.

[57]  M. Ichelpeuchmaur.  Gene transfer by guanidinium-cholesterol cationic lipids into airway epithelial cells in vitro and in vivo , 1997 .

[58]  J. Roth,et al.  Gene therapy for cancer: what have we done and where are we going? , 1997, Journal of the National Cancer Institute.

[59]  M. Heller,et al.  Artificial self-assembling systems for gene delivery , 1996 .